1.Research progress on the influence mechanism of insulin like growth factors system on growth restriction.
Acta Academiae Medicinae Sinicae 2011;33(1):18-21
Insulin-like growth factors (IGF) system plays an important role in regulating growth and development of children. The change of this system is closely related to growth restriction caused by various diseases. This article reviews the research progress on how IGF system affects growth.
Developmental Disabilities
;
metabolism
;
physiopathology
;
Humans
;
Somatomedins
;
metabolism
;
physiology
2.Obesity and Gastrointestinal Cancer-related Factor.
The Korean Journal of Gastroenterology 2012;59(1):8-15
Despite a higher incidence and less favorable outcome of malignant tumors in obese patients, much less recognized is the link between obesity and cancer. The mechanism of the association of obesity with carcinogenesis remains incompletely understood. Postulated mechanisms include insulin resistance, insulin-like growth factor signaling, chronic inflammation, immunomodulation, hyperglycemia-induced oxidative stress, and changes of intestinal microbiome. Insulin resistance leads to direct mitogenic and antiapoptotic signaling by insulin and the insulin-like growth factor axis. Obesity can be considered to be a state of chronic low-grade inflammation. In obesity, numerous proinflammatory cytokines are released from adipose tissue which may involve in carcinogenesis. Hyperglycemia in susceptible cells results in the overproduction of superoxide and this process is the key to initiating all damaging pathways related to diabetes. This hyperglycemia-induced oxidative stress could be one possible link among obesity, diabetes, and cancer development. The role of obesity-related changes in the intestinal microbiome in gastrointestinal carcinogenesis deserves further attention.
Adipokines/metabolism/physiology
;
Gastrointestinal Neoplasms/*etiology/microbiology
;
Humans
;
Inflammation/etiology
;
Insulin/metabolism/physiology
;
Leptin/metabolism/physiology
;
Obesity/*complications/immunology/metabolism
;
Oxidative Stress
;
Somatomedins/metabolism/physiology
3.Obesity and Pancreatic Diseases.
The Korean Journal of Gastroenterology 2012;59(1):35-39
Obesity is defined as BMI (calculated as weight in kg divided by height in m2) more than 30, and overweight is defined as BMI of 25-29.9. Obesity has been considered as a risk factor for pancreatic diseases, including pancreatitis and pancreatic cancer. Severe acute pancreatitis is significantly more frequent in obese patients. Furthermore, obese patients develop systemic and local complications of acute pancreatitis more frequently. The underlying mechanisms are increased inflammation and necrosis from increased amount of intra- and peri-pancreatic fat. In addition, obesity is a poor prognostic factor in acute pancreatitis, and overweight before disease onset appears to be a risk factor for chronic pancreatitis. Overweight and/or obesity are associated with greater risk of pancreatic cancer and younger age of onset. Physical activity appears to decrease the risk of pancreatic cancer, especially among those who are overweight. Long-standing diabetes increases the risk of pancreatic cancer. The pathogenic mechanism is that obesity and physical inactivity increase insulin resistance. In a state of hypersinulinemia, increased circulating level of insulin-like growth factor-1 induces cellular proliferation of pancreatic cancer. Obesity is associated with negative prognostic factor and increased mortality in pancreatic cancer. However, there are controversies regarding the effects of obesity on long-term post-operative results in the patient with pancreatic cancer.
Body Mass Index
;
Humans
;
Hypertriglyceridemia/complications
;
Obesity/*complications
;
Overweight
;
Oxidative Stress
;
Pancreatic Diseases/*etiology
;
Pancreatic Neoplasms/etiology
;
Somatomedins/metabolism/physiology
4.Obesity and Colorectal Cancer.
Soo Young NA ; Seung Jae MYUNG
The Korean Journal of Gastroenterology 2012;59(1):16-26
Obesity worldwide is constantly increasing. Obesity acts as an independent significant risk factor for malignant tumors of various organs including colorectal cancer. Visceral adipose tissue is physiologically more important than subcutaneous adipose tissue. The relative risk of colorectal cancer of obese patients is about 1.5 times higher than the normal-weight individuals, and obesity is also associated with premalignant colorectal adenoma. The colorectal cancer incidence of obese patients has gender-specific and site-specific characteristics that it is higher in men than women and in the colon than rectum. Obesity acts as a risk factor of colorectal carcinogenesis by several mechanisms. Isulin, insulin-like growth factor, leptin, adiponectin, microbiome, and cytokines of chronic inflammation etc. have been understood as its potential mechanisms. In addition, obesity in patients with colorectal cancer negatively affects the disease progression and response of chemotherapy. Although the evidence is not clear yet, there are some reports that weight loss as well as life-modification such as dietary change and physical activity can reduce the risk of colorectal cancer. It is very important knowledge in the point that obesity is a potentially modifiable risk factor that can alter the incidence and outcome of the colorectal cancer.
Adipokines/metabolism/physiology
;
Body Mass Index
;
Colorectal Neoplasms/*etiology/prevention & control
;
Energy Intake
;
Exercise
;
Humans
;
Insulin Resistance
;
Meta-Analysis as Topic
;
Obesity/*complications
;
Somatomedins/metabolism/physiology
;
Weight Loss
5.Functional roles and clinical values of insulin-like growth factor-binding protein-5 in different types of cancers.
Gökçe GÜLLÜ ; Sevgi KARABULUT ; Mustafa AKKIPRIK
Chinese Journal of Cancer 2012;31(6):266-280
Insulin-like growth factor-binding proteins(IGFBPs) are critical regulators of the mitogenic activity of insulin-like growth factors (IGFs). IGFBP5, one of these IGFBPs, has special structural features, including a nuclear transport domain, heparin-binding motif, and IGF/extracellular matrix/acid-labile subunit-binding sites. Furthermore, IGFBP5 has several functional effects on carcinogenesis and even normal cell processes, such as cell growth, death, motility, and tissue remodeling. These biological effects are sometimes related with IGF (IGF-dependent effects) and sometimes not (IGF-independent effects). The functional role of IGFBP5 is most likely determined in a cell-type and tissue-type specific manner but also depends on cell context, especially in terms of the diversity of interacting proteins and the potential for nuclear localization. Clinical findings show that IGFBP5 has the potential to be a useful clinical biomarker for predicting response to therapy and clinical outcome of cancer patients. In this review, we summarize the functional diversity and clinical importance of IGFBP5 in different types of cancers.
Animals
;
Apoptosis
;
Cell Differentiation
;
Cell Movement
;
Humans
;
Insulin-Like Growth Factor Binding Protein 5
;
genetics
;
metabolism
;
physiology
;
Neoplasm Metastasis
;
Neoplasms
;
metabolism
;
pathology
;
Protein Binding
;
RNA, Messenger
;
metabolism
;
Signal Transduction
;
Somatomedins
;
metabolism